MET and pancreatic neoplasm: DYN A1-8, MET, beta-END, and LEU (10−4 M; 10−6 M) did not affect the migration, chemotaxis, or invasion of pancreatic tumor cells (MIA PaCa-2, PANC-1, BxPC-3) [186] and the first three peptides mentioned did not alter the viability of the MIA PaCa-2 tumor cell line at the concentration administered (10−6 M) [172].